Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 86
Summary
- Conditions
- Lymphatic Metastasis
- Prostatic Neoplasms
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01962324
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Camilla Thellenberg Karlsson, MD Umea University